Literature DB >> 9012278

Neurologic findings in vitamin E deficiency.

M C Tanyel1, L D Mancano.   

Abstract

Vitamin E is one of the most important lipid-soluble antioxidant nutrients. Severe vitamin E deficiency can have a profound effect on the central nervous system. Cystic fibrosis, chronic cholestatic liver disease, abetalipoproteinemia, short bowel syndrome, isolated vitamin E deficiency syndrome and other malabsorption syndromes all may cause varying degrees of neurologic deficits due to related vitamin deficiencies. The classic abnormalities in vitamin E deficiency progress from hyporeflexia, ataxia, limitations in upward gaze and strabismus to long-tract defects, profound muscle weakness and visual field constriction. Patients with severe, prolonged deficiency may develop complete blindness, dementia and cardiac arrhythmias. Treatment must be tailored to the underlying cause of vitamin E deficiency and may include oral or parenteral vitamin supplementation. The more advanced the deficits, the more limited the response to therapy. Therefore, a good neurologic examination and periodic serum vitamin E levels are essential in patients at risk of vitamin E deficiency.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9012278

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  11 in total

Review 1.  The role of vitamins in cystic fibrosis.

Authors:  S B Carr; J McBratney
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

Review 2.  Therapeutic potential of vitamin E and its derivatives in traumatic brain injury-associated dementia.

Authors:  Jan Dobrovolny; Martin Smrcka; Julie Bienertova-Vasku
Journal:  Neurol Sci       Date:  2018-04-07       Impact factor: 3.307

Review 3.  Update on primary hypobetalipoproteinemia.

Authors:  Amanda J Hooper; John R Burnett
Journal:  Curr Atheroscler Rep       Date:  2014-07       Impact factor: 5.113

4.  Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis.

Authors:  J H Hoofnagle; M L Van Natta; D E Kleiner; J M Clark; K V Kowdley; R Loomba; B A Neuschwander-Tetri; A J Sanyal; J Tonascia
Journal:  Aliment Pharmacol Ther       Date:  2013-05-29       Impact factor: 8.171

Review 5.  'Non-neuronopathic' Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature.

Authors:  M Biegstraaten; I N van Schaik; J M F G Aerts; C E M Hollak
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.750

Review 6.  Delving into the complexity of hereditary spastic paraplegias: how unexpected phenotypes and inheritance modes are revolutionizing their nosology.

Authors:  Christelle Tesson; Jeanette Koht; Giovanni Stevanin
Journal:  Hum Genet       Date:  2015-03-11       Impact factor: 4.132

7.  Clinical, hematological, and imaging observations in a 25-year-old woman with abetalipoproteinemia.

Authors:  Madhu Nagappa; Parayil S Bindu; Sikandar Adwani; Sangeeta K Seshagiri; Jitender Saini; Sanjib Sinha; Arun B Taly
Journal:  Ann Indian Acad Neurol       Date:  2014-01       Impact factor: 1.383

8.  Prospective randomized controlled pilot study on the effects of almond consumption on skin lipids and wrinkles.

Authors:  Negar Foolad; Alexandra R Vaughn; Iryna Rybak; Waqas A Burney; Gwen M Chodur; John W Newman; Francene M Steinberg; Raja K Sivamani
Journal:  Phytother Res       Date:  2019-10-01       Impact factor: 5.878

Review 9.  Abetalipoproteinemia: two case reports and literature review.

Authors:  Rola Zamel; Razi Khan; Rebecca L Pollex; Robert A Hegele
Journal:  Orphanet J Rare Dis       Date:  2008-07-08       Impact factor: 4.123

10.  The maladies of malabsorption.

Authors:  Rashmi Patnayak; Vaikkakara Suresh; Amitabh Jena; Kadiyala Madhu; Bobbit Venkatesh Phaneendra; Venkatrami Reddy
Journal:  J Pediatr Neurosci       Date:  2016 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.